Report of the Committee for the Assessment of Biometric Aspects of Controlled Trials of Hypoglycemic Agents

JAMA. 1975 Feb 10;231(6):583-608.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Biometry
  • Cardiovascular Diseases / mortality
  • Clinical Trials as Topic
  • Diabetes Mellitus / diet therapy
  • Diabetes Mellitus / drug therapy*
  • Diet, Diabetic
  • Evaluation Studies as Topic
  • Female
  • Follow-Up Studies
  • Heart / drug effects
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Models, Theoretical
  • Operations Research
  • Phenformin / therapeutic use
  • Placebos
  • Sex Factors
  • Time Factors
  • Tolbutamide / adverse effects
  • Tolbutamide / therapeutic use

Substances

  • Hypoglycemic Agents
  • Placebos
  • Tolbutamide
  • Phenformin